Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Piotr Tylicki"'
Autor:
Magdalena Piotrowska, Maciej Zieliński, Leszek Tylicki, Bogdan Biedunkiewicz, Alicja Kubanek, Zuzanna Ślizień, Karolina Polewska, Piotr Tylicki, Marta Muchlado, Justyna Sakowska, Marcin Renke, Adam Sudoł, Małgorzata Dąbrowska, Monika Lichodziejewska-Niemierko, Tomasz Smiatacz, Alicja Dębska-Ślizień, Piotr Trzonkowski
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Vaccination against COVID-19 in patients with end-stage renal disease (ESRD) on replacement therapy and kidney transplant recipients (KTRs) is particularly important due to the high mortality rate. Here, we tested the local and systemic immunity to t
Externí odkaz:
https://doaj.org/article/e0a8124145e443249b7fc06582c7e168
Autor:
Bogdan Biedunkiewicz, Leszek Tylicki, Waldemar Ślizień, Monika Lichodziejewska-Niemierko, Małgorzata Dąbrowska, Alicja Kubanek, Sylwia Rodak, Karolina Polewska, Piotr Tylicki, Marcin Renke, Alicja Dębska-Ślizień
Publikováno v:
Vaccines, Vol 10, Iss 3, p 433 (2022)
The aim of this study was to analyze the waning of anti-spike (S) antibodies after mRNA vaccination against COVID-19 in maintenance dialysis patients, and to assess the safety and effectiveness of the complementary third dose. This was a prospective,
Externí odkaz:
https://doaj.org/article/c1c35b19166c41ac95d40c9f9457d51e
Autor:
Piotr Tylicki, Karolina Polewska, Aleksander Och, Anna Susmarska, Ewelina Puchalska-Reglińska, Aleksandra Parczewska, Bogdan Biedunkiewicz, Krzysztof Szabat, Marcin Renke, Leszek Tylicki, Alicja Dębska-Ślizień
Publikováno v:
Viruses, Vol 14, Iss 3, p 451 (2022)
The group most at risk of death due to COVID-19 are patients on maintenance hemodialysis (HD). The study aims to describe the clinical course of the early phase of SARS-CoV-2 infection and find predictors of the development of COVID-19 severe pneumon
Externí odkaz:
https://doaj.org/article/2f934c1da1df4472941554c6ebbd94ef
Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project
Autor:
Karolina Polewska, Piotr Tylicki, Bogdan Biedunkiewicz, Angelika Rucińska, Aleksandra Szydłowska, Alicja Kubanek, Iwona Rosenberg, Sylwia Rodak, Waldemar Ślizień, Marcin Renke, Alicja Dębska-Ślizień, Leszek Tylicki
Publikováno v:
Medicina, Vol 57, Iss 7, p 732 (2021)
Background and Objectives: The Pfizer-BioNTech (BNT162b2) COVID-19 mRNA vaccine has demonstrated excellent efficacy and safety in phase 3 trials. However, no dialyzed patients were included, and therefore safety data for this patient group is lacking
Externí odkaz:
https://doaj.org/article/167d14ae29b744f388555087c39ed8e7
Autor:
Bogdan Biedunkiewicz, Monika Lichodziejewska-Niemierko, Piotr Trzonkowski, Leszek Tylicki, Maciej Zieliński, Magdalena Piotrowska, Małgorzata Dąbrowska, Piotr Tylicki, Karolina Polewska, Alicja Dębska-Ślizień
Publikováno v:
Polish archives of internal medicine. 131(10)
Autor:
Krzysztof Szabat, Bogdan Biedunkiewicz, Aleksandra Parczewska, Karolina Polewska, Piotr Tylicki, Aleksander Och, Alicja Dębska-Ślizień, Leszek Tylicki, Ewelina Puchalska-Reglińska
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 4451, p 4451 (2021)
Volume 10
Issue 19
Journal of Clinical Medicine, Vol 10, Iss 4451, p 4451 (2021)
Volume 10
Issue 19
Background: After recovery from COVID-19, patients frequently face so-called “Post-COVID-19 Syndrome” defined by clusters of persistent symptoms lasting for >
12 weeks which may arise from any system in the body. The long-term health conse
12 weeks which may arise from any system in the body. The long-term health conse
Autor:
Karolina Polewska, Alicja Dębska-Ślizień, Piotr Tylicki, Leszek Tylicki, Bogdan Biedunkiewicz, Iwona Rosenberg, Sylwia Rodak, Waldemar Ślizień, Małgorzata Dąbrowska
Publikováno v:
Polish Archives of Internal Medicine.
Introduction: There is an urgent need to check the efficacy of SARS-CoV-2 vaccination among hemodialysis patients who are known to have large abnormalities of acquired immunity and a catastrophic risk of death from COVID-19. Objectives: In this cross
Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project
Autor:
Sylwia Rodak, Waldemar Ślizień, Piotr Tylicki, Karolina Polewska, Alicja Kubanek, Alicja Dębska-Ślizień, Aleksandra Szydłowska, Leszek Tylicki, Bogdan Biedunkiewicz, Marcin Renke, Angelika Rucińska, Iwona Rosenberg
Publikováno v:
Medicina
Volume 57
Issue 7
Medicina, Vol 57, Iss 732, p 732 (2021)
Volume 57
Issue 7
Medicina, Vol 57, Iss 732, p 732 (2021)
Background and Objectives: The Pfizer-BioNTech (BNT162b2) COVID-19 mRNA vaccine has demonstrated excellent efficacy and safety in phase 3 trials. However, no dialyzed patients were included, and therefore safety data for this patient group is lacking
Autor:
Ewelina, Puchalska-Reglińska, Alicja, Dębska-Ślizień, Bogdan, Biedunkiewicz, Piotr, Tylicki, Karolina, Polewska, Piotr, Jagodziński, Bolesław, Rutkowski, Ryszard, Gellert, Leszek, Tylicki
Publikováno v:
Polish archives of internal medicine. 131(7-8)
Preliminary reports suggested high incidence and mortality rates of SARS‑ CoV 2 infection in patients receiving kidney replacement therapy.We aimed to describe the incidence and outcomes of COVID‑ 19 in hemodialysis patients.We conducted a retros
Autor:
Karolina Polewska, Piotr Jagodziński, Bolesław Rutkowski, Alicja Dębska-Ślizień, Leszek Tylicki, Ryszard Gellert, Bogdan Biedunkiewicz, Ewelina Puchalska-Reglińska, Piotr Tylicki
Publikováno v:
Polish Archives of Internal Medicine.
INTRODUCTION: Preliminary reports suggest a high incidence and mortality with SARS-CoV-2 infection in patients receiving kidney replacement therapy. OBJECTIVES: To describe the incidence and outcomes of COVID-19 in hemodialyzed (HD) patients. PATIENT